Can thyroid-related SHBG elevation, zinc deficiency, and low DHEA-S reduce free androgen signaling despite high total testosterone?

Systemic hormonal, nutritional, and adrenal precursor pathways frequently converge to impair bioavailable androgen activity at the target-tissue level, even when standard serum panels show high total hormone concentrations.

Hormonal and precursor dynamics

• Thyroid-driven SHBG sequestration: Elevated thyroid hormones (T3/T4) upregulate hepatocyte nuclear factor-4alpha (HNF-4$\alpha$) and reduce hepatic palmitate. This drives HNF-4$\alpha$ to bind the proximal SHBG promoter, increasing circulating SHBG levels. High SHBG binds testosterone with high affinity, depleting the free, bioavailable fraction and creating a state of "hypertestosteronaemia" where elevated total testosterone masks a clinical free androgen deficiency.
• Adrenal precursor depletion: In aging males, dehydroepiandrosterone sulfate (DHEA-S) levels decline by 60% to 95%. Because DHEA-S serves as the primary systemic reservoir for local intracrine conversion to active testosterone and DHT in target tissues (utilizing local enzymes like steroid sulfatase, 3$\beta$-HSD, and 5$\alpha$-reductase), this decline deprives older men of 30% to 50% of their tissue-specific androgen pool.

Cellular and receptor mechanisms

• Zinc-dependent receptor instability: Zinc deficiency impairs Leydig cell steroidogenesis and shifts hepatic steroid conversion. At the cellular level, it destabilizes the androgen receptor (AR). The AR DNA-binding domain requires zinc to stabilize its two C4 zinc-finger motifs; without sufficient zinc, the receptor fails to maintain proper fold stability, leading to a reduced nuclear-to-cytosolic AR ratio and an inability to bind stably to androgen response elements (AREs) for gene transcription.

Bottom line

• Bottom line: Free androgen signaling can be profoundly suppressed despite high total circulating testosterone through a triad of thyroid-driven SHBG sequestration, zinc-deficiency-induced receptor instability, and an age-related 60% to 95% decline in the DHEA-S intracrine precursor pool.